Dr Ben Tombling
Genentech, South San Francisco, California, United States
Ben is a PhD graduate conducting further research at Genentech under the supervision of Dr Daniel Kirchhofer, and has worked previously for the peptide-based pharmaceutical company Protagonist Therapeutics in their Chemistry R&D team. Ben completed his PhD under the supervision of Dr Conan Wang and Prof David Craik at the Institute for Molecular Bioscience, The University of Queensland. Ben's research interests include developing chemical design strategies to design more efficacious therapeutics, improving the drug-like properties of peptide, and investigating protein-protein interactions and disease pathways.